Bortezomib var ikke genotoksisk i in vitro- analyser af mutagenicitet (Ames ’ test) og in vivo- analyser af mikronukleus hos mus.
Bortezomib was not genotoxic when tested in the in vitro mutagenicity assay (Ames assay) and in vivo micronucleus assay in mice.